When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Breakthrough antidepressants with fewer side effects could ...

   www.aol.com/finance/breakthrough-antidepressants...

   Ketamine’s antidepressant effects are part of what prompted researchers to explore other drugs that target glutamate—like the venerable cough suppressant dextromethorphan found in Robitussin ...

3. Serotonin–norepinephrine reuptake inhibitor - Wikipedia

   en.wikipedia.org/wiki/Serotonin–norepinephrine...

   SNRIs are delivered orally, usually in the form of capsules or tablets. It is recommended to take SNRIs in the morning with breakfast, which does not affect drug levels, but may help with certain side effects. [48] Norepinephrine has activating effects in the body and therefore can cause insomnia in some patients if taken at bedtime. [49]

4. Your Guide to the 6 Most Common Types of Depression Medications

   www.aol.com/6-types-depression-medications...

   Medications for Depression: An Overview. Antidepressants are a class of medications used very commonly to treat depression. In fact, nearly 13 percent of people 12 and over in the U.S. used ...

5. Your Guide to Every Antidepressant: SSRIs, SNRIs, TCAs & More

   www.aol.com/guide-every-antidepressant-ssris...

   List of SNRIs. Numerous SNRI antidepressants are currently prescribed to treat depression, as well as other mood disorders.They include: Desvenlafaxine (Pristiq) has been used as a treatment for ...

6. List of antidepressants - Wikipedia

   en.wikipedia.org/wiki/List_of_antidepressants

   This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification. Chemical/generic names are listed first, with brand names in parentheses.

7. Selective norepinephrine reuptake inhibitor - Wikipedia

   en.wikipedia.org/wiki/Selective_norepinephrine...

   The first commercially available selective norepinephrine reuptake inhibitor (sNRI) was reboxetine (Edronax) and was developed as a first-line therapy for major depressive disorder. [29] The selectivity of reboxetine for the norepinephrine transporter (NET) results in benign side effect profile because the drug is well tolerated. [11]